缺铁性贫血中血小板增多症的发生率、预测因素及血栓并发症特征
在36 327例IDA患者中,15 022例伴血小板增多,数据完整性评估后IDA患者血小板增多率为32.6%。IDA伴血小板增多患者血栓发生率为15.8%,IDA alone为7.8%;峰值血小板增多时血小板质量指数显著高于基线,且与峰值时血红蛋白呈强负相关;多变量模型显示峰值时血红蛋白降低与血小板计数升高之间存在显著预测关系。
要点
- IDA患者中约三分之一(32.6%)出现反应性血小板增多。
- IDA伴血小板增多患者血栓发生率为15.8%,IDA alone为7.8%,风险约2倍。
- 峰值血小板增多时血小板质量指数显著高于基线,并与血红蛋白强负相关。
核心结论
- 约三分之一的IDA患者出现反应性血小板增多。
- 与单纯IDA患者相比,IDA伴血小板增多患者的血栓风险约为2倍。
- 考虑到全球未治疗和治疗不足的IDA负担,充分的IDA治疗可能减少血栓并发症及相关发病率和死亡率。
研究设计与样本
- 收集人口统计学、血液学参数、血栓史及其他病史。
- 通过700例患者的详细人工病历审查评估查询数据的保真度,包括确认铁蛋白和血液学参数以及血小板增多的时间与临床关联。
- 共识别36 327例IDA,其中15 022例伴血小板增多。
主要发现
- 数据完整性评估后,IDA患者血小板增多率为32.6%。
- IDA患者血栓发生率为7.8%,IDA伴血小板增多患者为15.8%。
- 峰值血小板增多时血小板质量指数显著高于基线,且与峰值时血红蛋白呈强负相关。
- 多变量模型显示峰值时血红蛋白降低与血小板计数升高之间存在显著预测关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The association of thrombocytosis with iron deficiency anemia (IDA) is well-recognized, but data describing the rate, predictors, and risk of thrombotic complications associated with IDA-related thrombocytosis are limited. We queried an institutional patient data repository containing comprehensive chart data for over 6 million patients to identify IDA patients with and without thrombocytosis and thrombotic events over a 40-year time period (1979 to 2019). Demographics, hematological parameters, thrombosis history, and other medical history were collected. Fidelity of query data was assessed via detailed manual chart review of 700 patients, including confirmation of ferritin and hematologic parameters in addition to temporal and clinical association of thrombocytosis. Our queries identified 36 327 cases of IDA of which 15 022 had thrombocytosis. Following assessment for data integrity, we observed a thrombocytosis rate of 32.6% in patients with IDA. The rate of thrombosis was calculated to be 7.8% in patients with IDA and 15.8% in patients with IDA and thrombocytosis. Platelet mass index at time of peak thrombocytosis was significantly higher than at baseline and was strongly negatively correlated with hemoglobin at peak thrombocytosis. A multivariable model demonstrated a significant predictive relationship between decreasing hemoglobin and increasing platelet count at peak thrombocytosis. In conclusion, we observed reactive thrombocytosis in one-third of IDA patients, and a 2-fold thrombosis risk in patients with IDA and thrombocytosis compared with patients with IDA alone. Given the global burden of untreated and undertreated IDA, adequate IDA treatment may reduce thrombotic complications and associated morbidity and mortality.
引用
- Song AB, Kuter DJ, Al-Samkari H, et al. Characterization of the rate, predictors, and thrombotic complications of thrombocytosis in iron deficiency anemia. Am J Hematol. 2020. PMID: 32619079. doi:10.1002/ajh.25925
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。